| Unlock ST Premium FREE Trial: Discover top stock picks & smart tools | |
| Good morning! U.S. stock futures were little changed Wednesday morning as investors monitored diplomatic developments involving Iran and China alongside a strong technology rally. Dow Jones Industrial Average, S&P 500, and Nasdaq-100 futures hovered near flat after the Nasdaq Composite reached record highs for two consecutive sessions. President Trump is expected to meet Chinese President Xi Jinping at Joint Base Andrews, with discussions likely to cover trade, Iran, rare earths, and artificial intelligence. Tech investors are also watching AI policy developments, with Nvidia’s Jensen Huang, OpenAI’s Sam Altman, and Google’s Sundar Pichai attending a dinner with Trump and Xi. Meanwhile, hopes for improved U.S.-Iran relations pushed oil prices lower, with Brent below $100 and WTI under $90. | |
|
Top 5 Digital Assets Set to Surge Through 2025–2026
Inside, you’ll discover:
- ✅ How institutional capital is reshaping the crypto landscape
- ✅ Five digital assets positioned to benefit from the next growth wave
- ✅ Smart strategies for early positioning before mainstream momentum builds
👉 Access Your Free Report Here
By following the links above, you’re opting in to receive valuable updates from Wealthiest Investor News plus 2 bonus subscriptions. Your privacy is important to us. You can unsubscribe anytime. See our privacy policy for details.
Sponsored
| |
|
Vistagen Therapeutics Inc (VTGN) stock soared 61.73% to $0.40 in pre-market trading after announcing positive preliminary data from the PALISADE-4 Phase 3 study of fasedienol for treating social anxiety disorder.
Endovia Health Sciences Inc (AMEX: EDVA) shares are trading up 11.90% at $0.26 at the time of writing after announcing that it closed the initial funding from C/M Capital as part of its first investment tranche under the CannEpil® licensing agreement with Argent BioPharma Limited.
Decoy Therapeutics Inc (DCOY) rose more than 31.29% to $4.09 in pre-market trading today after announcing plans to explore its D-MAVs for additional candidates, including a pan-filovirus program under the FDA Animal Rule pathway.
TriSalus Life Sciences Inc (TLSI) jumped about 13.19% at $5.58 in pre-market trading Wednesday after announcing FDA 510(k) clearance for TriNav® Advance, the latest addition to its Pressure-Enabled Drug Delivery™ portfolio.
| |
|
The Magnificent Seven reshaped the market… But leadership never stays concentrated
forever. As these companies mature, new contenders begin to emerge quietly, long
before they dominate headlines.
These 7 stocks could be the next wave of market leaders: 7 companies with growing
influence, strong fundamentals, and the potential to define the market’s next phase.
The full list is available here FREE
Sponsored
| |
| Top Upgrades & Downgrades | |
|
Citigroup turned bullish on Fifth Third Bancorp (FITB), upgrading the stock to Buy and assigning a $62 price target, representing potential upside of 17.51% from Tuesday's close.
Eldorado Gold Corp (EGO) has won the favor of BofA Securities' equity research team. The firm upgraded the shares from Underperform to Buy and moved its price target to $54, suggesting 20.40% additional upside for the stock.
Brinker International Inc (EAT) received an upgrade from analysts at Northcoast, who also set their one-year price target on the stock to $275. They changed their rating on EAT to Buy from Neutral in a recently issued research note.
HSBC Securities reduced its rating on Netflix Inc (NFLX) stock to Hold from Buy and assigned the price target to $76.
Morgan Stanley analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Telefonaktiebolaget LM Ericsson - ADR (ERIC) has been changed to Underweight from Equal-Weight and the new price target is set at $9.
Analysts at Jefferies downgraded Valero Energy Corp (VLO) stock to Hold from Buy, and the new price target is set at $401.
| |
|
Grab Holdings Ltd (GRAB) President and COO, Hungate Alexander Charles, declared the purchase of shares taking place on Sep 21 '26 at $2.89 for some 299571 shares. The transaction amount was around $866,839.
Bullfrog AI Holdings Inc (BFRG) Chief Financial Officer, Blacher Joshua bought on Sep 22 '26 a total of 50000 shares at $0.53 on average. The purchase cost the insider an estimated $26,425.
Apple Inc (AAPL) SVP, GC and Government Affairs, Newstead Jennifer announced the sale of shares taking place on Sep 15 '26 at $330.19 for some 1438 shares. The total came to more than $474,813.
Plug Power Inc (PLUG) CSO & GM EMEA, Haycraft Benjamin sold on Sep 18 '26 a total 200000 shares at $2.14 on average. The insider’s sale generated proceeds of almost $428,300.
| |
|
For years, investors ignored nuclear.
That may turn out to be a costly mistake.
Energy reliability, security, and supply constraints have pushed nuclear back into the spotlight - and the market is starting to respond. But many stocks tied to the sector still trade as if nothing has changed.
Our analysts believe that gap won’t last.
7 Top Nuclear Stocks to Buy Now shows how to get exposure before the nuclear re-rating plays out into 2026.
Download the report free now - once it’s paywalled, this window closes.
Sponsored
| |
|
Top US earnings releases scheduled for today include Stitch Fix Inc (SFIX). It will announce its July 2026 financial results. The company is expected to report earnings of -$0.06 per share from revenues of $324.65M in the three-month period.
Analysts expect NeoVolta Inc (NEOV) to report a net income (adjusted) of -$0.09 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended June 2026 is predicted to come in at $1.27M.
H.B. Fuller Company (FUL), due to announce earnings after the market closes today, is expected to report earnings of $1.46 per share on revenues of $945.53M for the recently concluded three-month period.
| |
| That's it for today. Thanks for reading. Good luck out there! Best Regards, Stocks Telegraph Team | |
| Disclaimer: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. | |
|
